Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:56:17.601Z.
Calculation as of: 2026-10-06T21:56:17.601Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8c517f571e23d8c9640577b72a0d01a1674ca2fb527f0620093024032568825b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Cogent Biosciences, Inc.
Market Cap
$5.19B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.20B
Operating Cash Flow Yield
5.89%
TTM Avg
5.66%
3Y Avg
3.62%
5Y Avg
2.97%
Market Cap
$5.20B
Operating Cash Flow Yield
5.61%
TTM Avg
5.53%
3Y Avg
6.14%
5Y Avg
6.08%
Market Cap
$5.21B
Operating Cash Flow Yield
1.78%
TTM Avg
1.20%
3Y Avg
1.20%
5Y Avg
1.20%
Market Cap
$5.21B
Operating Cash Flow Yield
N/A
TTM Avg
9.45%
3Y Avg
5.30%
5Y Avg
5.30%
Market Cap
$5.09B
Operating Cash Flow Yield
N/A
TTM Avg
4.29%
3Y Avg
4.29%
5Y Avg
4.29%
Market Cap
$5.07B
Operating Cash Flow Yield
5.59%
TTM Avg
6.10%
3Y Avg
4.38%
5Y Avg
3.97%
Market Cap
$5.32B
Operating Cash Flow Yield
N/A
TTM Avg
13.90%
3Y Avg
13.90%
5Y Avg
13.90%
Market Cap
$5.06B
Operating Cash Flow Yield
5.79%
TTM Avg
6.39%
3Y Avg
4.03%
5Y Avg
4.03%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.19B | N/A | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.20B | 5.89% | 5.66% | 3.62% | 2.97% |
| Sotera Health Company (SHC)vs › | $5.20B | 5.61% | 5.53% | 6.14% | 6.08% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 1.78% | 1.20% | 1.20% | 1.20% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | N/A | 9.45% | 5.30% | 5.30% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | N/A | 4.29% | 4.29% | 4.29% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 5.59% | 6.10% | 4.38% | 3.97% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | N/A | 13.90% | 13.90% | 13.90% |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 5.79% | 6.39% | 4.03% | 4.03% |
| Erasca, Inc. (ERAS)vs › | $4.96B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
